Penny Smith

Background

About Penny Smith

At Washington University School of Medicine, my work centers on the groundbreaking field of psychedelic-assisted therapy, specifically targeting treatment-resistant depression with psilocybin. My collaboration with the UK biotech company Compass Pathways is at the forefront of clinical research, aiming to establish new, FDA-approved treatment. With over a decade of clinical and program experience, my proficiency in mindfulness-based therapy is integral to my practice, both in clinical trials and as a psychotherapist. The holistic approach I employ merges traditional psychotherapy with innovative somatic and mindfulness-based interventions, reflecting my commitment to ethical and transformative mental health care. As a consultant, my expertise in project management enhances a team's strategic alignment with their core values and objectives. Our team's dedication to integrating evidence-based practices with compassionate care is paving the way for advancements in mental health services.